Recent clinical and preclinical studies have demonstrated that metformin not only ameliorates insulin sensitivity, but also facilitates glucose-lipid reverse transport, alleviates hormone imbalances induced by glucose metabolic irregularities, and ameliorates symptoms associated with hormonal dysregulation in patients with PCOS (Shen et al., 2022
Therapeutic Peptide Integration offers unprecedented opportunities to enhance surgical recovery through precise biological signaling
Rather than checking for expansive features, clinicians may evaluate for behavior activation (such as marked irritability, psychomotor agitation, and psychic tension) in patients with bipolar depression as markers for TEAS.[164] In the absence of robust empirical data, expert consensus currently guides the management of TEAS
Statistical tests with multiple comparison were performed as indicated in the figure legends
The GLP-1s and GIPs approved by the FDA for weight loss are: Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)
While GLP-1 medications show promise for a select group of patients, significant challenges remain in ensuring their appropriate use and affordability
